Semaglutide showed fewer serious adverse events compared to placebo in long-term studies
Patients who are aware of the potential risks, like an increased risk for dysesthesia, allergic reactions, or heart rhythm changes, can make informed decisions and set expectations for those initial weeks of treatment
Molecules 23(8):2058 Bahar B, Tuncel AF, Holmes EW, Holmes DT (2017) An interactive website for analytical method comparison and bias estimation
The Bottom Line Brand-name and compounded tirzepatide deliver the same active ingredient through different regulatory pathways
What countries have generic semaglutide, if any
To participate in a fast-growing but competitive and complicated market, GLP-1 originators will need to adopt a differentiated patient- and customer-centric strategy leveraging both internal and external resources to optimize product positioning, building brand equity, integrating software and device solutions beyond the drug itself, and exploring innovative channels